Company intelligence / Profile preview

Genecast

Ownership: Private
Development stage: Commercial

Overview

Genecast is a leading precision oncology diagnostics company with operations in China and South Korea, specializing in liquid biopsy, multiomics molecular testing, and companion diagnostics. Its proprietary ADPS™ technology enables ultra-sensitive detection of cancer mutations from blood samples, supporting early diagnosis, therapy selection, recurrence monitoring, and personalized treatment decisions. The company has launched several commercial diagnostic products including EGFR mutation tests for non-small cell lung cancer.

Therapeutic areas: Oncology
Modalities: Diagnostic testLiquid biopsyPCR-based assayNext Generation Sequencing (NGS)
Industry: Molecular Diagnostics

Partnerships

Agendia (MammaPrint license in China)

Beyond the preview

Go deeper on Genecast.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genecast.

Explore the full profile